Vol 21 No 4 (2015)
Journal of Commercial Biotechnology
Journal of Commercial Biotechnology
Subscribe
Current
Archives
Search
About
About the Journal
Submissions
Editorial Team
Privacy Statement
Contact
Register
Login
Register
Login
Vol 21 No 4 (2015)
Published January 11, 2016
Commentary
Ananda Mohan Chakrabarty
US Supreme Court’s Decision on the Patent Ineligibility of Human Genes - BRCA1/BRCA2 as Products of Nature
PDF
Abhishek Kumar Yadav
Flavonoids – World Healthiest Gift for the Benefit of Human Health
Requires Subscription or Fee
PDF
Peter J. Pitts, Robert Goldberg
Undermining Patient Values: The ASCO Value in Cancer Care Task Force Framework
Requires Subscription or Fee
PDF
Articles
Andrew Henderson
Investment in Life Sciences in Scotland: Challenges and Opportunities
Requires Subscription or Fee
PDF
Sholeh Azar, Timothy Ken Mackey
Crowdfunding: A New Untapped Opportunity for Biotechnology Start-ups?
Requires Subscription or Fee
PDF
ajay gautam
EmergingCo: A Virtual “South-South†Biotech Model
PDF
Legal and Regulatory Updates
Peter J. Pitts
The FDA's Quality Revolution
Requires Subscription or Fee
PDF
Denise Golgher, Roberto Rodrigues, Rodrigo Couto Massafera
Biosimilars in Brazil: developments in 2015 and business perspectives
Requires Subscription or Fee
PDF
×
Username
*
Required
Password
*
Required
Forgot your password?
Keep me logged in
Login
No account?
Register here